ZNTL - Zentalis Pharmaceuticals Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

ZNTL is currently covered by 7 analysts with average potential upside of $19.33 (44.62%) backed by 12 price targets and 33 ratings. Documented since 28-Apr-2020. Analyst's average stock valuation to be materialised ratio is 44.58% with an average time for price targets to be met of 78.5 days.

Most recent stock forecast was given by ANDREW FEIN from HCWAINWRIGHT on 02-Mar-2023.

Highest price target for ZNTL is 80, Lowest price target is 19, average price target is 49.5.

Currently, out of the existing stock ratings of ZNTL - 22 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

55

$37.85 (220.70%)

55

23 days ago

2/5 (40%)

$27.33 (78.61%)

123

Buy

32

$14.85 (86.59%)

89

4 months 11 days ago

1/3 (33.33%)

$13.04 (31.52%)

222

Buy

28

$10.85 (63.27%)

45

4 months 14 days ago

1/2 (50%)

$7.84 (27.60%)

31

Buy

42

$24.85 (144.90%)

97

7 months 15 days ago

3/6 (50%)

$12.99 (25.78%)

58

Buy

74

$56.85 (331.49%)

94

11 months 14 days ago

1/3 (33.33%)

$31.67 (74.16%)

33

Show more analysts

What is ZNTL(Zentalis Pharmaceuticals Inc) average time for price targets to be met?

On average it took 78.5 days on average for the stock forecasts to be realized with a an average price target met ratio 44.58

Which analyst has the current highest performing score on ZNTL(Zentalis Pharmaceuticals Inc) with a proven track record?

ANDREW FEIN